Finance

Beta
Lists
RLYB:NASDAQ
Rallybio Corp
$15.82
-0.78%
(-0.12) 1D
Jul 2, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RLYB...
Open
$15.76
High
$15.99
Low
$15.70
Mkt. cap
83.79M
Avg. vol.
64.12K
Volume
15.17K
52-wk high
$17.57
52-wk low
$2.55
EPS
-$1.37
Beta
-0.90
Shares outstanding
5.30M
No. of employees
9
Open
$15.76
High
$15.99
Low
$15.70
Mkt. cap
83.79M
Avg. vol.
64.12K
Volume
15.17K
52-wk high
$17.57
52-wk low
$2.55
EPS
-$1.37
Beta
-0.90
Shares outstanding
5.30M
No. of employees
9
News stories
From sources across the web
About Rallybio Corp
CEO-
Employees9
Founded2018
HeadquartersNew Haven, Connecticut, United States
SectorBiotechnology
Analyst
Recommendation
Action
Price target
Projected
Date
Gavin Clark-Gartner
Evercore ISI
Hold
Maintained
$8.00
-49.4%
12/18/2025
Ritu Baral
TD Cowen
Buy
Maintained
-
-
11/10/2025
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$1.46 / -$1.20
-21.67%miss
Revenue / Est. (USD)
212.00K / 0.00
+∞%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
212.00K
212.00K
222.00K
212.00K
Cost of goods sold
6.07M
4.14M
3.66M
2.87M
Cost of revenue
6.07M
4.14M
3.66M
2.87M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.20M
2.99M
2.98M
5.37M
Operating expense
4.20M
2.99M
2.98M
5.37M
Total operating expenses
10.27M
7.14M
6.63M
8.24M
Operating income
-10.06M
-6.92M
-6.41M
-8.03M
Other non operating income
118.00K
-
-
254.00K
EBT including unusual items
-9.70M
16.02M
-5.85M
-8.28M
EBT excluding unusual items
-9.70M
-6.46M
-5.85M
-7.57M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.70M
16.02M
-5.85M
-8.28M
Net profit margin
-4,576.89%
7,554.72%
-2,636.04%
-3,904.72%
Earnings per share
-1.76
2.88
-1.52
-1.46
Interest and investment income
523.00K
462.00K
560.00K
201.00K
Interest expense
-
-
-
-
Net interest expenses
523.00K
462.00K
560.00K
201.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.03M
-6.89M
-6.41M
-8.03M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more